Recall Register

Food, drugs, devices › Philips North America, LLC

Device recall: Philips HeartStart MRx devices in use with the M3539A AC Power Module: M3535A, M3536A, M3536M, M3536MC, M3536M2, M3536M3

FDA enforcement event 82750 · Class II · initiated 7 Jun 2019 · status Terminated · terminated 8 May 2020

DeviceVoluntary: Firm initiated1 product recordAndover, MA

FDA enforcement event 82750 is a device recall by Philips North America, LLC of Andover, MA, initiated 7 Jun 2019 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 88% of the 968 device enforcement events initiated in 2019 carry the same class.

Status: Terminated, terminated 8 May 2020. Initiation: voluntary: firm initiated. Philips North America, LLC has 129 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Philips North America, LLC, Andover, MA.

Reason for recall

"The AC power module may fail at a higher than expected rate. If a fully charged battery is not properly installed, the HeartStart MRx may lose all power and fail to operate. Interruption of monitoring and failure or delay in the delivery of a shock or pacing can occur. A faulty AC Power Module may also fail to charge the battery."

Distribution

"Nationwide domestic distribution. Worldwide distribution."

Product records

Recall numberProductQuantityClassStatusReport date
Z-1923-2019Philips HeartStart MRx devices in use with the M3539A AC Power Module: M3535A, M3536A, M3536M, M3536MC, M3536M2, M3536M3, M3536M4, M3536M5, M3536M6, M3536M7, M3536M8, M3536M997,794 UnitsClass IITerminated17 Jul 2019

Context

88%of 2019 device events are Class II968 events that year
1product record in this eventfirm median: 1
129events on this register for the firm

Other enforcement events for Philips North America, LLC

InitiatedProduct (first record)TypeClassRecords
7 Aug 2026Philips Brilliance. Models: Brilliance iCT, Brilliance iCT Upgrades, Brilliance iCT SP. Software 4.1.10.x Product Codes:DeviceClass II4
1 Jul 2026Cardiac Workstation 5000. Product Number: 860439.DeviceClass II2
5 Jun 2026Philips Telemetry Monitor 5500 1.4 GHz. Model Number: 867232. Includes the following system descriptions: TELE Monitor 5DeviceClass II1
26 May 2026Philips Avalon Fetal Monitor, FM20, Part number M2702A, Part M2703ADeviceClass II2
1 May 2026DigitalDiagnost C90 Flex/Value/Chest/ER. Model Number: 712035.DeviceClass II1
7 Jan 2026Brilliance iCT; Product Code (REF): 728306;DeviceClass II4
12 Dec 2025Philips Smart-hopping 2.0 AP 1.4 GHz. Patient Monitor.DeviceClass II1
31 Oct 2025IntelliVue MP2. Product Number: M8102A.DeviceClass II22
29 Oct 2025Incisive CT; Software Version Number: 4.5, 5.0, 5.1;DeviceClass II2
13 Aug 2025Philips CT systems labeled as the following: 1. Brilliance CT 40 Channel, Model Number: 728235. 2. Brilliance CT 64 ChanDeviceClass II10

All 129 events for Philips North America, LLC

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "The AC power module may fail at a higher than expected rate. If a fully charged battery is not properly installed, the HeartStart MRx may lose all power and fail to operate. Interruption of monitoring and failure or delay in the delivery of a shock or pacing can occur. A faulty AC Power Module may also fail to charge the battery."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Nationwide domestic distribution. Worldwide distribution."

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 8 May 2020. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.